Sfoglia per Autore
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy
2023-01-01 Erica Mina, Elisabeth Wyart, Roberta Sartori, Elia Angelino, Ivan Zaggia, Valentina Rausch, Mara Maldotti, Alessia Pagani, Myriam Y. Hsu, Alberto Friziero, Cosimo Sperti, Alessio Menga, Andrea Graziani, Emilio Hirsch, Salvatore Oliviero, Marco Sandri, Laura Conti, Léon Kautz, Laura Silvestri, Paolo E. Porporato
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3
2022-01-01 Masgras I.; Cannino G.; Ciscato F.; Sanchez-Martin C.; Darvishi F.B.; Scantamburlo F.; Pizzi M.; Menga A.; Fregona D.; Castegna A.; Rasola A.
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia
2022-01-01 Wyart E.; Hsu M.Y.; Sartori R.; Mina E.; Rausch V.; Pierobon E.S.; Mezzanotte M.; Pezzini C.; Bindels L.B.; Lauria A.; Penna F.; Hirsch E.; Martini M.; Mazzone M.; Roetto A.; Geninatti Crich S.; Prenen H.; Sandri M.; Menga A.; Porporato P.E.
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages
2021-01-01 Menga A.; Favia M.; Spera I.; Vegliante M.C.; Gissi R.; De Grassi A.; Laera L.; Campanella A.; Gerbino A.; Carra G.; Canton M.; Loizzi V.; Pierri C.L.; Cormio G.; Mazzone M.; Castegna A.
The J2-immortalized murine macrophage cell line displays phenotypical and metabolic features of primary BMDMs in their M1 and M2 polarization state
2021-01-01 Spera I.; Sanchez-Rodriguez R.; Favia M.; Menga A.; Venegas F.C.; Angioni R.; Munari F.; Lanza M.; Campanella A.; Pierri C.L.; Canton M.; Castegna A.
IκBα targeting promotes oxidative stress-dependent cell death
2021-01-01 Carrà, Giovanna; Ermondi, Giuseppe; Riganti, Chiara; Righi, Luisella; Caron, Giulia; Menga, Alessio; Capelletto, Enrica; Maffeo, Beatrice; Lingua, Marcello Francesco; Fusella, Federica; Volante, Marco; Taulli, Riccardo; Guerrasio, Angelo; Novello, Silvia; Brancaccio, Mara; Piazza, Rocco; Morotti, Alessandro
Cachexia, a Systemic Disease beyond Muscle Atrophy
2020-01-01 Elisabeth Wyart, Laure B. Bindels, Erica Mina, Alessio Menga, Serena Stanga, Paolo E. Porporato
Pharmacological targets of metabolism in disease: Opportunities from macrophages
2020-01-01 Castegna A.; Gissi R.; Menga A.; Montopoli M.; Favia M.; Viola A.; Canton M.
Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism?
2020-01-01 Serra M.; Columbano A.; Ammarah U.; Mazzone M.; Menga A.
Impact of immunometabolism on cancer metastasis: A focus on T cells and macrophages
2020-01-01 Flerin N.C.; Pinioti S.; Menga A.; Castegna A.; Mazzone M.
Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages
2020-01-01 Menga A.; Serra M.; Todisco S.; Riera-Domingo C.; Ammarah U.; Ehling M.; Palmieri E.M.; Di Noia M.A.; Gissi R.; Favia M.; Pierri C.L.; Porporato P.E.; Castegna A.; Mazzone M.
Editorial: Metabolism Meets Function: Untangling the Cross-Talk Between Signaling and Metabolism
2020-01-01 Castegna A.; McVicar D.W.; Campanella A.; Palmieri E.M.; Menga A.; Porporato P.E.
The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: Biological pathways and therapeutic implication
2019-01-01 De Nola R.; Menga A.; Castegna A.; Loizzi V.; Ranieri G.; Cicinelli E.; Cormio G.
Glutamine synthetase: Localization dictates outcome
2018-01-01 Castegna A.; Menga A.
Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury
2018-01-01 Costiniti V.; Spera I.; Menabo R.; Palmieri E.M.; Menga A.; Scarcia P.; Porcelli V.; Gissi R.; Castegna A.; Canton M.
FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells
2018-01-01 Antonia Cianciulli; Alessio Menga; Palmieri Ferdinando; Vito Iacobazzi
SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency
2018-01-01 Punzi G.; Porcelli V.; Ruggiu M.; Hossain M.F.; Menga A.; Scarcia P.; Castegna A.; Gorgoglione R.; Pierri C.L.; Laera L.; Lasorsa F.M.; Paradies E.; Pisano I.; Marobbio C.M.T.; Lamantea E.; Ghezzi D.; Tiranti V.; Giannattasio S.; Donati M.A.; Guerrini R.; Palmieri L.; Palmieri F.; De Grassi A.
Metabolism and TAM functions—it takes two to tango
2018-01-01 Mazzone M.; Menga A.; Castegna A.
Mitochondrial carriers in inflammation induced by bacterial endotoxin and cytokines
2017-01-01 Iacobazzi V.; Infantino V.; Castegna A.; Menga A.; Palmieri E.M.; Convertini P.; Palmieri F.
Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells
2017-01-01 Palmieri E.M.; Menga A.; Lebrun A.; Hooper D.C.; Butterfield D.A.; Mazzone M.; Castegna A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy | 2023 | Erica Mina, Elisabeth Wyart, Roberta Sartori, Elia Angelino, Ivan Zaggia, Valentina Rausch, Mara Maldotti, Alessia Pagani, Myriam Y. Hsu, Alberto Friziero, Cosimo Sperti, Alessio Menga, Andrea Graziani, Emilio Hirsch, Salvatore Oliviero, Marco Sandri, Laura Conti, Léon Kautz, Laura Silvestri, Paolo E. Porporato | |
| Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3 | 2022 | Masgras I.; Cannino G.; Ciscato F.; Sanchez-Martin C.; Darvishi F.B.; Scantamburlo F.; Pizzi M.; Menga A.; Fregona D.; Castegna A.; Rasola A. | |
| Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia | 2022 | Wyart E.; Hsu M.Y.; Sartori R.; Mina E.; Rausch V.; Pierobon E.S.; Mezzanotte M.; Pezzini C.; Bindels L.B.; Lauria A.; Penna F.; Hirsch E.; Martini M.; Mazzone M.; Roetto A.; Geninatti Crich S.; Prenen H.; Sandri M.; Menga A.; Porporato P.E. | |
| N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages | 2021 | Menga A.; Favia M.; Spera I.; Vegliante M.C.; Gissi R.; De Grassi A.; Laera L.; Campanella A.; Gerbino A.; Carra G.; Canton M.; Loizzi V.; Pierri C.L.; Cormio G.; Mazzone M.; Castegna A. | |
| The J2-immortalized murine macrophage cell line displays phenotypical and metabolic features of primary BMDMs in their M1 and M2 polarization state | 2021 | Spera I.; Sanchez-Rodriguez R.; Favia M.; Menga A.; Venegas F.C.; Angioni R.; Munari F.; Lanza M.; Campanella A.; Pierri C.L.; Canton M.; Castegna A. | |
| IκBα targeting promotes oxidative stress-dependent cell death | 2021 | Carrà, Giovanna; Ermondi, Giuseppe; Riganti, Chiara; Righi, Luisella; Caron, Giulia; Menga, Alessio; Capelletto, Enrica; Maffeo, Beatrice; Lingua, Marcello Francesco; Fusella, Federica; Volante, Marco; Taulli, Riccardo; Guerrasio, Angelo; Novello, Silvia; Brancaccio, Mara; Piazza, Rocco; Morotti, Alessandro | |
| Cachexia, a Systemic Disease beyond Muscle Atrophy | 2020 | Elisabeth Wyart, Laure B. Bindels, Erica Mina, Alessio Menga, Serena Stanga, Paolo E. Porporato | |
| Pharmacological targets of metabolism in disease: Opportunities from macrophages | 2020 | Castegna A.; Gissi R.; Menga A.; Montopoli M.; Favia M.; Viola A.; Canton M. | |
| Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism? | 2020 | Serra M.; Columbano A.; Ammarah U.; Mazzone M.; Menga A. | |
| Impact of immunometabolism on cancer metastasis: A focus on T cells and macrophages | 2020 | Flerin N.C.; Pinioti S.; Menga A.; Castegna A.; Mazzone M. | |
| Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages | 2020 | Menga A.; Serra M.; Todisco S.; Riera-Domingo C.; Ammarah U.; Ehling M.; Palmieri E.M.; Di Noia M.A.; Gissi R.; Favia M.; Pierri C.L.; Porporato P.E.; Castegna A.; Mazzone M. | |
| Editorial: Metabolism Meets Function: Untangling the Cross-Talk Between Signaling and Metabolism | 2020 | Castegna A.; McVicar D.W.; Campanella A.; Palmieri E.M.; Menga A.; Porporato P.E. | |
| The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: Biological pathways and therapeutic implication | 2019 | De Nola R.; Menga A.; Castegna A.; Loizzi V.; Ranieri G.; Cicinelli E.; Cormio G. | |
| Glutamine synthetase: Localization dictates outcome | 2018 | Castegna A.; Menga A. | |
| Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury | 2018 | Costiniti V.; Spera I.; Menabo R.; Palmieri E.M.; Menga A.; Scarcia P.; Porcelli V.; Gissi R.; Castegna A.; Canton M. | |
| FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells | 2018 | Antonia Cianciulli; Alessio Menga; Palmieri Ferdinando; Vito Iacobazzi | |
| SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency | 2018 | Punzi G.; Porcelli V.; Ruggiu M.; Hossain M.F.; Menga A.; Scarcia P.; Castegna A.; Gorgoglione R.; Pierri C.L.; Laera L.; Lasorsa F.M.; Paradies E.; Pisano I.; Marobbio C.M.T.; Lamantea E.; Ghezzi D.; Tiranti V.; Giannattasio S.; Donati M.A.; Guerrini R.; Palmieri L.; Palmieri F.; De Grassi A. | |
| Metabolism and TAM functions—it takes two to tango | 2018 | Mazzone M.; Menga A.; Castegna A. | |
| Mitochondrial carriers in inflammation induced by bacterial endotoxin and cytokines | 2017 | Iacobazzi V.; Infantino V.; Castegna A.; Menga A.; Palmieri E.M.; Convertini P.; Palmieri F. | |
| Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells | 2017 | Palmieri E.M.; Menga A.; Lebrun A.; Hooper D.C.; Butterfield D.A.; Mazzone M.; Castegna A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile